The prescription drug user fee program is likely to include a minimum carryover balance beginning in fiscal year 2023, as the US Food and Drug Administration and industry attempt to better control the excess revenue collected each year.
New details of the PDUFA VII discussions posted 24 March indicate the FDA will slowly raise the carryover balance floor...